Shammas Bajwa
Internal Medicine · Ou Health Partners Inc
Credentials: · · ·
History
- 2025–2026
- 2014–2018
Research
Efficacy and Safety of RET-Specific Kinase Inhibitors in RET-Altered Cancers: A Systematic Review
Systematic review or meta-analysis · Cancer Investigation · 2023 · 4 citations
Cureus · 2022 · 4 citations
Efficacy and toxicity of surufatinib in neuroendocrine tumors: A systematic review and meta-analysis
Systematic review or meta-analysis · Journal of Neuroendocrinology · 2022 · 4 citations
- WA
4 papers · 4 as a resident
2 papers · 2 as a fellow
- SS
2 papers
- UB
2 papers · 2 as a fellow
- AA
1 paper · 1 as a resident
1 paper · 1 as a resident
- AB
1 paper · 1 as a resident
- BR
1 paper
